"Cell Engineering" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods and techniques used to modify or select cells and develop conditions for growing cells for biosynthetic production of molecules (METABOLIC ENGINEERING), for generation of tissue structures and organs in vitro (TISSUE ENGINEERING), or for other BIOENGINEERING research objectives.
| Descriptor ID |
D060846
|
| MeSH Number(s) |
E05.481.500.311 J01.293.069.249
|
| Concept/Terms |
Cell Engineering- Cell Engineering
- Engineering, Cell
- Cellular Engineering
- Engineering, Cellular
|
Below are MeSH descriptors whose meaning is more general than "Cell Engineering".
Below are MeSH descriptors whose meaning is more specific than "Cell Engineering".
This graph shows the total number of publications written about "Cell Engineering" by people in this website by year, and whether "Cell Engineering" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 1 | 3 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Engineering" by people in Profiles.
-
Recent advances in biomedical, biosensor and clinical measurement devices for use in humans and the potential application of these technologies for the study of physiology and disease in wild animals. Philos Trans R Soc Lond B Biol Sci. 2021 08 16; 376(1831):20200228.
-
MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2. Sci Rep. 2021 03 08; 11(1):5376.
-
Engineering antibody therapies for protective immunity. J Thorac Cardiovasc Surg. 2021 04; 161(4):1358-1361.
-
B-cell engineering: A promising approach towards vaccine development for COVID-19. Med Hypotheses. 2020 Nov; 144:109948.
-
A systems biology pipeline identifies regulatory networks for stem cell engineering. Nat Biotechnol. 2019 07; 37(7):810-818.
-
Small-molecule control of antibody N-glycosylation in engineered mammalian cells. Nat Chem Biol. 2019 07; 15(7):730-736.
-
A Slick Solution to a Sticky Problem. Biochemistry. 2018 10 16; 57(41):5923-5924.
-
Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance. J Immunol Methods. 2018 07; 458:74-82.
-
Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia. Front Immunol. 2018; 9:239.
-
Booming cancer immunotherapy fighting tumors. Sci China Life Sci. 2017 12; 60(12):1445-1449.